Viking Therapeutics Inc.

NASDAQ: VKTX · Real-Time Price · USD
40.49
0.25 (0.62%)
At close: Aug 15, 2025, 1:20 PM

Viking Therapeutics Revenue

Viking Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Viking Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
45
Market Cap
4.55B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.